315 related articles for article (PubMed ID: 37900041)
1. SARS-CoV-2 incidence, seroprevalence, and COVID-19 vaccination coverage in the homeless population: a systematic review and meta-analysis.
Liang Y; Sun Q; Liu Q; Pang Y; Tang S
Front Public Health; 2023; 11():1044788. PubMed ID: 37900041
[TBL] [Abstract][Full Text] [Related]
2. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD;
PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774
[TBL] [Abstract][Full Text] [Related]
3. Update on SARS-CoV-2 seroprevalence: regional and worldwide.
Rostami A; Sepidarkish M; Fazlzadeh A; Mokdad AH; Sattarnezhad A; Esfandyari S; Riahi SM; Mollalo A; Dooki ME; Bayani M; Nazemipour M; Mansournia MA; Hotez PJ; Gasser RB
Clin Microbiol Infect; 2021 Dec; 27(12):1762-1771. PubMed ID: 34582980
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis.
Liu Q; Qin C; Liu M; Liu J
Infect Dis Poverty; 2021 Nov; 10(1):132. PubMed ID: 34776011
[TBL] [Abstract][Full Text] [Related]
6. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type.
Totolian AA; Smirnov VS; Krasnov AA; Ramsay ES; Dedkov VG; Popova AY
Viruses; 2023 Oct; 15(11):. PubMed ID: 38005859
[No Abstract] [Full Text] [Related]
8. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.
Rostami A; Sepidarkish M; Leeflang MMG; Riahi SM; Nourollahpour Shiadeh M; Esfandyari S; Mokdad AH; Hotez PJ; Gasser RB
Clin Microbiol Infect; 2021 Mar; 27(3):331-340. PubMed ID: 33228974
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis.
Azami M; Moradi Y; Moradkhani A; Aghaei A
Eur J Med Res; 2022 Jun; 27(1):81. PubMed ID: 35655237
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 among people experiencing homelessness in England: a modelling study.
Lewer D; Braithwaite I; Bullock M; Eyre MT; White PJ; Aldridge RW; Story A; Hayward AC
Lancet Respir Med; 2020 Dec; 8(12):1181-1191. PubMed ID: 32979308
[TBL] [Abstract][Full Text] [Related]
11. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 antibody prevalence among homeless people and shelter workers in Denmark: a nationwide cross-sectional study.
Eriksen ARR; Fogh K; Hasselbalch RB; Bundgaard H; Nielsen SD; Jørgensen CS; Scharff BFSS; Erikstrup C; Sækmose SG; Holm DK; Aagaard B; Kristensen JH; Bødker CA; Norsk JB; Nielsen PB; Østergaard L; Ellermann-Eriksen S; Andersen B; Nielsen H; Johansen IS; Wiese L; Simonsen L; K Fischer T; Folke F; Lippert F; Ostrowski SR; Ethelberg S; Koch A; Vangsted AM; Krause T; Fomsgaard A; Nielsen C; Ullum H; Skov R; Iversen K
BMC Public Health; 2022 Jun; 22(1):1261. PubMed ID: 35761270
[TBL] [Abstract][Full Text] [Related]
13. Can we get out of the COVID pandemic without adequate vaccination coverage in the pediatric population?
Esposito S; Giordano R; Paini G; Puntoni M; Principi N; Caminiti C
Ital J Pediatr; 2022 Aug; 48(1):150. PubMed ID: 35986340
[TBL] [Abstract][Full Text] [Related]
14. The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review.
Vaselli NM; Hungerford D; Shenton B; Khashkhusha A; Cunliffe NA; French N
PLoS One; 2021; 16(11):e0250541. PubMed ID: 34727115
[TBL] [Abstract][Full Text] [Related]
15. Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March-May 2020).
Husain M; Rachline A; Cousien A; Rolland S; Rouzaud C; Ferre VM; Gomez MV; Le Teurnier M; Wicky-Thisse M; Descamps D; Yazdanpanah Y; Charpentier C; Pasquet-Cadre A
Clin Microbiol Infect; 2021 Oct; 27(10):1520.e1-1520.e5. PubMed ID: 34111590
[TBL] [Abstract][Full Text] [Related]
16. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
[TBL] [Abstract][Full Text] [Related]
17. Pooled rates and demographics of POTS following SARS-CoV-2 infection versus COVID-19 vaccination: Systematic review and meta-analysis.
Yong SJ; Halim A; Liu S; Halim M; Alshehri AA; Alshahrani MA; Alshahrani MM; Alfaraj AH; Alburaiky LM; Khamis F; Muzaheed ; AlShehail BM; Alfaresi M; Al Azmi R; Albayat H; Al Kaabi NA; Alhajri M; Al Amri KAS; Alsalman J; Algosaibi SA; Al Fares MA; Almanaa TN; Almutawif YA; Mohapatra RK; Rabaan AA
Auton Neurosci; 2023 Dec; 250():103132. PubMed ID: 38000119
[TBL] [Abstract][Full Text] [Related]
18. Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts.
Tran TN; Wikle NB; Albert E; Inam H; Strong E; Brinda K; Leighow SM; Yang F; Hossain S; Pritchard JR; Chan P; Hanage WP; Hanks EM; Boni MF
BMC Med; 2021 Jul; 19(1):162. PubMed ID: 34253200
[TBL] [Abstract][Full Text] [Related]
19. Cumulative incidence of SARS-CoV-2 infection within the homeless population: insights from a city-wide longitudinal study.
Mosnier E; Loubiere S; Monfardini E; Alibert A; Landier J; Ninoves L; Bosetti T; Auquier P; Mosnier M; Wakap SN; Warszawski J; Tinland A
BMJ Open; 2023 Feb; 13(2):e065734. PubMed ID: 36822808
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021.
Lewis HC; Ware H; Whelan M; Subissi L; Li Z; Ma X; Nardone A; Valenciano M; Cheng B; Noel K; Cao C; Yanes-Lane M; Herring BL; Talisuna A; Ngoy N; Balde T; Clifton D; Van Kerkhove MD; Buckeridge D; Bobrovitz N; Okeibunor J; Arora RK; Bergeri I;
BMJ Glob Health; 2022 Aug; 7(8):. PubMed ID: 35998978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
